Search details
1.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Article
in English
| MEDLINE | ID: mdl-35839452
2.
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.
J Natl Compr Canc Netw
; 21(2): 108-115, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36791762
3.
Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing.
Ann Pharmacother
; 57(1): 29-35, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35511200
4.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet
; 398(10299): 491-502, 2021 08 07.
Article
in English
| MEDLINE | ID: mdl-34097852
5.
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 194(4): 690-700, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34296427
6.
In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden.
Cytotherapy
; 23(4): 320-328, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33262074
7.
Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy.
Support Care Cancer
; 29(3): 1387-1394, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-32666212
8.
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Blood
; 131(25): 2836-2845, 2018 06 21.
Article
in English
| MEDLINE | ID: mdl-29549175
9.
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw
; 18(5): 599-634, 2020 05 01.
Article
in English
| MEDLINE | ID: mdl-32519831
10.
CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.
Blood
; 127(26): 3360-8, 2016 06 30.
Article
in English
| MEDLINE | ID: mdl-27207788
11.
Extramedullary early T-cell precursor acute lymphoblastic lymphoma presenting as blast crisis of CML.
Blood
; 136(9): 1112, 2020 08 27.
Article
in English
| MEDLINE | ID: mdl-32853380
12.
A Case of Subacute Encephalopathy Developing After Treatment With Clofarabine and Methotrexate That Resolved With Corticosteroids.
Am J Ther
; 23(3): e937-40, 2016.
Article
in English
| MEDLINE | ID: mdl-24987945
13.
Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review.
Support Care Cancer
; 24(8): 3343-6, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26971955
14.
Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir.
Support Care Cancer
; 24(8): 3603-6, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27165053
15.
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemic.
Lancet Oncol
; 21(6): 759-760, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32410877
16.
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.
Acta Haematol
; 133(4): 347-53, 2015.
Article
in English
| MEDLINE | ID: mdl-25677780
17.
Successful treatment of refractory Guillain-Barré syndrome with alemtuzumab in a patient with chronic lymphocytic leukemia.
Acta Haematol
; 132(2): 240-3, 2014.
Article
in English
| MEDLINE | ID: mdl-24853856
18.
Pregabalin's abuse potential: a mini review focusing on the pharmacological profile.
Int J Clin Pharmacol Ther
; 52(8): 709-16, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24849194
19.
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.
Bone Marrow Transplant
; 59(3): 366-372, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38177222
20.
Outcomes of Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Large B-Cell Lymphoma (LBCL): A Single-Institution Experience.
Cancers (Basel)
; 15(18)2023 Sep 21.
Article
in English
| MEDLINE | ID: mdl-37760639